| Gerri C Adkins, | |
|
5330 Laytham Pike, Laytham Pk., Mayslick, KY 41055-8930 | |
| (606) 763-6255 | |
| (606) 763-6245 |
| Full Name | Gerri C Adkins |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 5330 Laytham Pike, Mayslick, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841311362 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | KY2539 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Gerri C Adkins, 5330 Laytham Pike, Mayslick, KY 41055-8930 Ph: (606) 763-6255 | Gerri C Adkins, 5330 Laytham Pike, Laytham Pk., Mayslick, KY 41055-8930 Ph: (606) 763-6255 |
News Archive
JumpStart Inc., the Northeast Ohio venture development organization that accelerates the progress of high growth early-stage businesses, and Portal Capital, a Cleveland-based private equity firm investing in life science companies, each announce an investment commitment of $250,000 in TheraVasc Inc., for a total commitment of $500,000. The
With their waiting rooms crowded and exam rooms full, many physicians say they are too busy to be good communicators. Those who study physician time-management think otherwise. Certain communication skills can foster efficiency and effectiveness during an office visit without sacrificing rapport with patients, according to researchers at the University of Washington (UW) and the University of Rochester.
A study by scientists at the University of Glasgow, which reveals the critical role a common cancer-associated gene plays in lymphoma development, could lead to improved treatments for a range of cancers.
The Multiple Myeloma Research Foundation (MMRF) raised over $1.8 million at its 13th annual Fall Gala held on Saturday evening in Greenwich, Conn. Funds raised at this premier fundraising event, attended by more than 1,000 guests, will support the MMRF's efforts to accelerate the development of the next generation of treatments for patients with multiple myeloma, a rare and incurable blood cancer, and to find a cure for the disease.
AbbVie, a global biopharmaceutical company, today announced that results from a Phase 1b trial of investigational venetoclax, a novel inhibitor of the B-cell lymphoma-2 (BCL-2) protein that is being developed in partnership with Genentech and Roche, in combination with bortezomib and dexamethasone, showed an 83 percent overall response rate (n=5/6) in bortezomib-naive patients with relapsed/refractory (R/R) multiple myeloma, including two patients who achieved complete responses.1 These data will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting on Sunday, May 31, in Chicago.
› Verified 6 days ago
Candance Kuhl, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5330 Laytham Pike, Mayslick, KY 41055 Phone: 606-763-6255 Fax: 606-763-6245 | |
Kari Osborne, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5330 Laytham Pike, Mayslick, KY 41055 Phone: 606-584-1169 Fax: 800-584-1465 | |
Amy Miller, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5330 Laytham Pike, Mayslick, KY 41055 Phone: 606-763-6255 Fax: 606-763-6245 | |
Emmi Marcum, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5330 Laytham Pike, Mayslick, KY 41055 Phone: 606-763-6255 Fax: 606-763-6245 | |
Denetra P Keeton, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5330 Laytham Pike, Mayslick, KY 41055 Phone: 606-763-6255 Fax: 606-763-6245 | |
Melissa L Coleman, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5330 Laytham Pike, Mayslick, KY 41055 Phone: 606-763-6255 | |
Mrs. Lisa Livingood, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5330 Laytham Pike, Mayslick, KY 41055 Phone: 606-763-6255 Fax: 800-584-1465 |